Companies · Other Health Care

NarrativeDx Inc.

AUSTIN · Other Health Care

Diligence memoA one-page analyst read on NarrativeDx Inc. — recommendation, valuation, rhythm, risks.
$7.4M
Total raised · real
3
Rounds
0.4×
Latest step-up
Top 30%
Sector rank · raised
Seed
Latest stage · inferred · Wed Apr 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

NarrativeDx Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.66× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.2 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

NarrativeDx Inc. is one of 5377 Other Health Care companies tracked from AUSTIN. By capital raised it ranks in the upper tier (ahead of 71% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2013
Year incorporated
2018-04-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2015-03-25 Raised $718K (real) Modeled valuation $22M (est)$718K$22MPre-Seed2015Seed · 2017-05-05 Raised $3.7M (real) Modeled valuation $91M (est)$3.7M$91MSeed2017Seed · 2018-04-25 Raised $3.0M (real) Modeled valuation $74M (est)$3.0M$74MSeed2018Seed · 2018-04-25 Raised $1.1M (real) Modeled valuation $27M (est)$1.1M$27MSeed2018+$3.7M+$3.0M+$1.1MCumulative $8.4M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$718K · 2015
Seed$3.7M · 2017
Seed extension$3.0M · 2018
Seed extension$1.1M · 2018

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$73.7M
Base estimate est.
$2.5M
Conservative case
$578.5M
Upside case
$14.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $22.1M · 2015-03-252015Seed · modeled $91.0M · 2017-05-05Seed · modeled $73.7M · 2018-04-25Seed · modeled $26.6M · 2018-04-252018
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
8.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$2.4M/yr
Capital velocity
11.3 yr
On record since
2015
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 3.0× above median
This company$7.4M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.6× of median
This company$1.1M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 3.3× above median
This company$73.7M
Sector median$22.1M

Raised more than 71% of sector peers (real $). Modeled value above 73% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #42 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)NarrativeDx Inc. (this company) Raised $7.4M · modeled $73.7M (est)NarrativeDx Inc.
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
NarrativeDx Inc. this companySeed$7.4M$73.7M1.66×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$718K2015-03-25$4.0M$22.1M85%
Seed$3.7M2017-05-05$18.4M$91.0M90%
Seed$3.0M2018-04-25$14.9M$73.7M90%
Seed$1.1M2018-04-25$5.4M$26.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$718K2015-03-25
    • First recorded raise — entered as Pre-Seed.
    • 14 investors on this round.
  2. Seed$3.7M2017-05-05
    • Raised again after 25 mo — slower than the ~14 mo sector norm.
    • Round 5.1× larger than the prior — scaling up.
    • 20 investors on this round.
  3. Seed$3.0M2018-04-25
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 10 investors on this round.
  4. Seed$1.1M2018-04-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.8× smaller than the prior — bridge or down round.
    • 5 investors on this round.
Intelligence
2019 ~Q2
Modeled next raise · ~12mo cadence
$1.1M
Modeled next size est.range $1.1M$1.7M
0.4×
Last step-up
$2.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Mark Bakken23 other2017-05
John Paulos6 other2018-04
WILLIAM SCHMIDT6 other2017-05
Jay Shah5 other2017-05
Kyle Robertson3 other2015-03
Ben Scott2 other2017-05
Shakeel Rashed1 other2015-03
Marc Yagjian2015-03
Patricia Riskind2018-04
Senem Guney2015-03
Registry & provenance

NarrativeDx Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1649092
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
ImageMoverMD, Inc.Other Health CareSeed$4.4M$39.7Mnetwork2 shared operators · same sector · same stage
Allergy Amulet, Inc.Other Health CareSeed$5.6M$1.9Mnetwork1 shared operator · same sector · same stage
VedaPointe, LLCOther Health CareSeed$3.4M$11.8Mnetwork1 shared operator · same sector · same stage
Nurse Disrupted, Inc.Other Health CareSeed$1.6M$7.8Mnetwork1 shared operator · same sector · same stage
Agathos IncOther Health CareSeries A$5.9M$80.5Mnetwork1 shared operator · same sector
ForSight VISION6, Inc.Other Health CareSeed$7.5M$74.4Msame sector · same stage
Health Integrated IncOther Health CareSeed$7.2M$74.4Msame sector · same stage
Lifevantage CorpOther Health CareSeed$7.6M$65.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Genomedx Inc.Other Health CareSeries B$176.3M89%
ArcherDX, Inc.Other Health CareSeries C$35.6M87%
PrismHealthDX, Inc.Other Health CareSeries A$113.0M86%
StataDx, Inc.Other Health CareSeed$9.1M86%
MetaModix, Inc.Other Health CareSeed$4.2M86%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M85%
SensorRX, Inc.Other Health CareSeed$38.3M85%
ActX, Inc.Other Health CareSeries A$50.8M85%
Frequently asked
How much funding has NarrativeDx Inc. raised?
NarrativeDx Inc. has raised approximately $7.4M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is NarrativeDx Inc.'s estimated valuation?
Provath's modeled valuation for NarrativeDx Inc. is approximately $73.7M (modeled range $2.5M–$578.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NarrativeDx Inc. at?
NarrativeDx Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Wed Apr 25.
What does NarrativeDx Inc. do and where is it based?
NarrativeDx Inc. operates in the Other Health Care sector, based in AUSTIN.
Explore related

See where NarrativeDx Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NarrativeDx Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.